9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

Re-directed T Cells for the Treatment (FAP)-Positive Malignant Pleural Mesothelioma

Top West Virginia Mesothelioma Lawyer | Law Firm | Attorney | GPW > Re-directed T Cells for the Treatment (FAP)-Positive Malignant Pleural Mesothelioma

Re-directed T Cells for the Treatment (FAP)-Positive Malignant Pleural Mesothelioma

Estimated reading time: < 1 min

Condition: Malignant Pleural Mesothelioma

Estimated Enrollment: 4

Gender: All

Min Age: 18 Years

Age Group: Adult, Older Adult

Current Status: Completed

Study Results: No Results Available

Outcome Measures: Safety,  ,  ,

Interventions: Adoptive Transfer of re-directed T cells,

Phase:

Study Type: Interventional

Study Design: Intervention Model: Sequential Assignment, Masking: None (Open Label), Primary Purpose: Treatment,

Primary Completion Date: March 22, 2019

Completion Date: July 18, 2019

Last  Posted Date: August 7, 2019

Location: University Hospital Zurich, Division of Oncology, Zurich, ZH, Switzerland

Website Link: https://ClinicalTrials.gov/show/NCT01722149

Was this article helpful?
Dislike 0